search
 

 

Beyond Basics
Common Therapies

Drug Therapies

A major goal of drug therapies is to reduce the incapacitating diarrhea that is a recurring problem in the management of SBS, and to enable the patient to participate more fully in normal daily activities.

Diarrhea. The cause of diarrhea needs to be identified before appropriate treatment can be initiated. Opiates are the most commonly used medications for the treatment of diarrhea in SBS. These antidiarrheal agents control diarrhea by reducing intestinal secretion, or by promoting the absorption of nutrients and fluid and reducing intestinal motility. These drugs should be taken on a regular basis, approximately one hour before meals.

Cholestyramine is used when bile acid loss results in watery stools, or cholerrheic diarrhea. It is usually used in patients with a colon and with resection of less than 100 cm (about 39 inches) of terminal ileum. This drug lessens diarrhea by attaching to bile acids, which reduces their ability to impair fluid and electrolyte absorption in the colon. However, cholestyramine may also impair absorption of fat-soluble vitamins (A, D, E, and K), folate, calcium, and iron. If the cause of the diarrhea is fat malabsorption rather than bile acid malabsorption, taking this medication could exacerbate the diarrhea by further depleting the amount of bile acids and leaving more fat in the lumen, thereby increasing steatorrhea.

Octreotide works by suppressing pancreatic and gastric secretions. It is used when diarrhea is severe. While octreotide may be used in SBS patients to reduce diarrhea, it has the potential to impair intestinal adaptation, which is an undesirable side effect of using this drug.

Gastric hypersecretion. Gastric hypersecretion is common following intestinal resection, and can result in excessive fluid and electrolyte loss and compromised intestinal absorption. The excess stomach acid produced by this condition flows into the duodenum and creates an acidic environment. This inactivates pancreatic enzymes and bile acids, which work best in a neutral environment, and, in turn, results in reduced intestinal fat absorption and steatorrhea. Histamine-2 blockers or proton pump inhibitors can be used to treat this condition. They work by reducing the production of stomach acid. These are the same types of drugs often used to treat heartburn and acid reflux disease.
Bacterial overgrowth. The control of bacterial overgrowth in the small intestine is a key component in the management of SBS. Treatment with a monthly or bimonthly rotation of an oral broad-spectrum antibiotic that is effective against a wide variety of bacteria can be administered for the first five days of each month. For patients requiring continuous treatment with antibiotics, the antibiotics should be changed every two to three months to prevent the growth of resistant bacteria.
Pancreatic enzymes. Pancreatic supplements, taken with meals, may be useful for reducing steatorrhea. It is thought that pancreatic supplements with high fat-digesting activity could compensate for the pancreatic enzyme deficiency that might be caused by excessive gastric secretions, inadequate mixing of enzymes with ingested food, or inadequate stimulation of pancreatic secretion. In general, pancreatic enzymes are used to aid digestion.

 

 

This information is provided as a general educational service
and is not intended to recommend any particular treatment plan
or to replace the advice of physicians. It is important that patients
seek and rely on the advice of a healthcare professional
about their individual medical conditions.

  
  
Copyright © 2004 - 2007
All rights reserved.